Rituximab, bendamustine and cytarabine (RBAC500) as induction therapy in elderly patients with mantle cell lymphoma: a phase 2 study from the Fondazione Italiana Linfomi.

Rituximab, bendamustine and cytarabine (RBAC500) as induction therapy in elderly patients with mantle cell lymphoma: a phase 2 study from the Fondazione Italiana Linfomi. Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):19-20 Authors: Moskowitz CH PMID: 26452087 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26452087?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - November 18, 2015 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research